Cargando…
Antibiotics and Lipid-Modifying Agents: Potential Drug–Drug Interactions and Their Clinical Implications
Evidence-based prescribing requires taking into consideration the many aspects of optimal drug administration (e.g., dosage, comorbidities, co-administered drugs, etc.). A key issue is the administration of drugs for acute disorders that may potentially interfere with previously prescribed long-term...
Autores principales: | Spanakis, Marios, Alon-Ellenbogen, Danny, Ioannou, Petros, Spernovasilis, Nikolaos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457919/ https://www.ncbi.nlm.nih.gov/pubmed/37624085 http://dx.doi.org/10.3390/pharmacy11040130 |
Ejemplares similares
-
Drug-Drug Interactions among Patients Hospitalized with COVID-19 in Greece
por: Spanakis, Marios, et al.
Publicado: (2022) -
Drug Interactions for Patients with Respiratory Diseases Receiving COVID-19 Emerged Treatments
por: Spanakis, Marios, et al.
Publicado: (2021) -
Evaluation of Drug Interactions in Hospitalized Patients with Respiratory Disorders in Greece
por: Spanakis, Marios, et al.
Publicado: (2023) -
PharmActa: Empowering Patients to Avoid Clinical Significant Drug–Herb Interactions
por: Spanakis, Marios, et al.
Publicado: (2019) -
Prevalence and Clinical Significance of Drug–Drug and Drug–Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece
por: Spanakis, Marios, et al.
Publicado: (2021)